Daily Newsletter

29 September 2023

Daily Newsletter

29 September 2023

AccuLine, Mayo Clinic partner to advance coronary artery disease solution

The system leverages AI-driven signal processing algorithms and enables the assessment of the individual’s coronary arteries.

RanjithKumar Dharma September 29 2023

eHealth Ventures portfolio company AccuLine and Mayo Clinic have entered a know-how license agreement to advance the former’s CORA solution designed to detect coronary artery disease (CAD) early.

The agreement will allow Mayo Clinic to become a shareholder in AccuLine.

The CORA system is designed to simultaneously measure and interpret several biological indicators, covering respiratory rhythm, cardiac electrical activity and blood oxygen saturation.

Leveraging artificial intelligence (AI)-driven signal processing algorithms, the system enables the assessment of the individual’s coronary arteries.

The technology is based on the two novel bio-signal discoveries in the electric activity of the heart, correlating with CAD.

With a specificity and sensitivity of 85%, the system was able to differentiate between individuals with and without notable coronary heart disease in a clinical trial.

The collaboration aims to adapt the system for the US market, which involves defining features of the product and designing a comprehensive clinical trial in line with FDA approval requirements.

Furthermore, the technology will be integrated as the preferred diagnostic tool for cardiologists and general practitioners for early detection of CAD.

AccuLine CEO Moshe Barel said: “We are thrilled to join forces with Mayo Clinic in this pivotal initiative aimed at reducing the impact of heart attacks on mortality and patient well-being.

“Mayo Clinic's extensive clinical experience and expertise in diagnosing and treating cardiac conditions are important assets as we refine CORA, enabling the identification of individuals at high risk for heart attacks years in advance.”

Generative AI set to transform the medical devices industry

Generative AI can improve personalized healthcare by collecting data from patients via wearable devices, which can provide continuous, real-time data that can complement traditional data sources such as imaging, patient records, and more. It can also enhance existing imaging techniques by generating high-quality images of organs using data from low-resolution images (such as ultrasounds). However, the collection and use of patient healthcare data through AI medical products could conflict with regulations around the globe.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close